Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David MoherOttawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. [email protected]A. LiberatiCentro Cochrane Italiano, Istituto Ricerche Farmacologiche Mario Negri, Milan, ItalyJennifer TetzlaffOttawa Methods Centre, Ottawa Hospital Research Institute, Ottawa, Ontario, CanadaDouglas G. AltmanCentre for Statistics in Medicine, University of Oxford, Oxford, United Kingdomfor the PRISMA Group
2009en
ABI
Annotatsiya
Structured summary 2 Provide a structured summary including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings, systematic review registration number Flow of information through the different phases of a systematic review No of records identified through database searching No of additional records identified through other sources No of records after duplicates removed No of studies included in qualitative synthesis No of studies included in quantitative synthesis (meta-analysis)
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
8 ta iqtibos0 ta foydalanilgan manba